These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12813467)

  • 61. Dasatinib synergizes with both cytotoxic and signal transduction inhibitors in heterogeneous breast cancer cell lines--lessons for design of combination targeted therapy.
    Park BJ; Whichard ZL; Corey SJ
    Cancer Lett; 2012 Jul; 320(1):104-10. PubMed ID: 22306341
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regulation of TOR by small GTPases.
    Durán RV; Hall MN
    EMBO Rep; 2012 Feb; 13(2):121-8. PubMed ID: 22240970
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Putting the pH into phosphatidic acid signaling.
    Shin JJ; Loewen CJ
    BMC Biol; 2011 Dec; 9():85. PubMed ID: 22136116
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Choline metabolism in malignant transformation.
    Glunde K; Bhujwalla ZM; Ronen SM
    Nat Rev Cancer; 2011 Nov; 11(12):835-48. PubMed ID: 22089420
    [TBL] [Abstract][Full Text] [Related]  

  • 65. High-dose rapamycin induces apoptosis in human cancer cells by dissociating mTOR complex 1 and suppressing phosphorylation of 4E-BP1.
    Yellen P; Saqcena M; Salloum D; Feng J; Preda A; Xu L; Rodrik-Outmezguine V; Foster DA
    Cell Cycle; 2011 Nov; 10(22):3948-56. PubMed ID: 22071574
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phospholipase D mediates nutrient input to mammalian target of rapamycin complex 1 (mTORC1).
    Xu L; Salloum D; Medlin PS; Saqcena M; Yellen P; Perrella B; Foster DA
    J Biol Chem; 2011 Jul; 286(29):25477-86. PubMed ID: 21622984
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle.
    Hornberger TA
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1267-76. PubMed ID: 21621634
    [TBL] [Abstract][Full Text] [Related]  

  • 68. H2S protects hippocampal neurons from anoxia-reoxygenation through cAMP-mediated PI3K/Akt/p70S6K cell-survival signaling pathways.
    Shao JL; Wan XH; Chen Y; Bi C; Chen HM; Zhong Y; Heng XH; Qian JQ
    J Mol Neurosci; 2011 Mar; 43(3):453-60. PubMed ID: 20967511
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.
    Toschi A; Lee E; Thompson S; Gadir N; Yellen P; Drain CM; Ohh M; Foster DA
    Cancer Lett; 2010 Dec; 299(1):72-9. PubMed ID: 20805015
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New concepts in phospholipase D signaling in inflammation and cancer.
    Gomez-Cambronero J
    ScientificWorldJournal; 2010 Jul; 10():1356-69. PubMed ID: 20623096
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeting mTOR in cancer: renal cell is just a beginning.
    Azim H; Azim HA; Escudier B
    Target Oncol; 2010 Dec; 5(4):269-80. PubMed ID: 20563661
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.
    Winter JN; Fox TE; Kester M; Jefferson LS; Kimball SR
    Am J Physiol Cell Physiol; 2010 Aug; 299(2):C335-44. PubMed ID: 20427710
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reduced mortality and moderate alcohol consumption: the phospholipase D-mTOR connection.
    Foster DA
    Cell Cycle; 2010 Apr; 9(7):1291-4. PubMed ID: 20372065
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phosphatidic acid is a leukocyte chemoattractant that acts through S6 kinase signaling.
    Frondorf K; Henkels KM; Frohman MA; Gomez-Cambronero J
    J Biol Chem; 2010 May; 285(21):15837-47. PubMed ID: 20304930
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A comprehensive model that explains the regulation of phospholipase D2 activity by phosphorylation-dephosphorylation.
    Henkels KM; Peng HJ; Frondorf K; Gomez-Cambronero J
    Mol Cell Biol; 2010 May; 30(9):2251-63. PubMed ID: 20176813
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Delayed correlation of mRNA and protein expression in rapamycin-treated cells and a role for Ggc1 in cellular sensitivity to rapamycin.
    Fournier ML; Paulson A; Pavelka N; Mosley AL; Gaudenz K; Bradford WD; Glynn E; Li H; Sardiu ME; Fleharty B; Seidel C; Florens L; Washburn MP
    Mol Cell Proteomics; 2010 Feb; 9(2):271-84. PubMed ID: 19955083
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells.
    Kang DW; Lee JY; Oh DH; Park SY; Woo TM; Kim MK; Park MH; Jang YH; Min do S
    Exp Mol Med; 2009 Sep; 41(9):678-85. PubMed ID: 19478552
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting mTOR with rapamycin: one dose does not fit all.
    Foster DA; Toschi A
    Cell Cycle; 2009 Apr; 8(7):1026-9. PubMed ID: 19270529
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.
    Foster DA
    Biochim Biophys Acta; 2009 Sep; 1791(9):949-55. PubMed ID: 19264150
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Akt-dependent and -independent mechanisms of mTOR regulation in cancer.
    Memmott RM; Dennis PA
    Cell Signal; 2009 May; 21(5):656-64. PubMed ID: 19166931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.